Venous thrombosis causes an estimated 50,000 deaths per year in the US and has an incidence of 1 per 1000 annually. There are many reported risk factors including a genetic element that can contribute to thrombosis. Cardiovascular disease is a leading cause of death for both men and women in most racial ethnic groups.
Please note: Licences for the in vitro diagnostic analysis of gene mutations detected by these reagents may be required and are the responsibility of the reagent purchaser.
TRP
The Elucigene TRP (Thrombosis Risk Panel) provides laboratories with a simple and accurate means of routinely testing for the three most relevant mutations implicated in the risk of developing venous thromboembolism.
The factor V Leiden (R506Q) mutation is the most common inherited form of thrombophilia, but the Prothrombin 20210A (factor II) and MTHFR (methylenetetrahyrofolate reductase) C677T also contribute toward increased risk.
• How to Order • Cat. No. TH003B2
TRP Downloads
Information sheet
Safety sheet
Instructions for use
TRP w/o MTHFR
As ELUCIGENE TRP (Thrombosis Risk Panel) but does not include detection of the C677T MTHFR polymorphism.
• How to Order • Cat. No. TH002B2
